Evidence map›Paper›PMID 31295315›Full record

ArticlePloS one2019

Undetected tuberculosis at enrollment and after hospitalization in medical and oncology wards in Botswana.

Yeonsoo Baik, Othusitse Fane, Qiao Wang, Chawangwa Modongo, Cynthia Caiphus, Surbhi Grover, Nicola M Zetola, Sanghyuk S Shin

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yeonsoo BaikDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, United States of America.
Othusitse FaneBotswana-Upenn Partnership, Gaborone, Botswana.
Qiao WangSue & Bill Gross School of Nursing, University of California, Irvine, Irvine, CA, United States of America.
Chawangwa ModongoBotswana-Upenn Partnership, Gaborone, Botswana.
Cynthia CaiphusPrincess Marina Hospital, Botswana Ministry of Health, Gaborone, Botswana.
Surbhi GroverDepartment of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA, United States of America.
Nicola M ZetolaBotswana-Upenn Partnership, Gaborone, Botswana.
Sanghyuk S ShinSue & Bill Gross School of Nursing, University of California, Irvine, Irvine, CA, United States of America.ORCID 0000-0001-9982-4373

Funding

Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHEN, IRVIN S.Y. · 1991 to 2018
$39.9M
Dynamics of TB and MDR TB transmission in areas with high HIV prevalenceR01AI097045 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ZETOLA, NICOLA MARIO · 2011 to 2015
$2.9M
Prognostic value of quantitative HPV viral load in determining cervical cancer treatment response and recurrenceK08CA230170 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GROVER, SURBHI · 2019 to 2023
$1.4M
The Effect of Mixed-strain Mycobacterium tuberculosis Infections on TB Treatment Outcomes in Botswana: A Retrospective Cohort Study.K01AI118559 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHIN, SANGHYUK SAM · 2015 to 2019
$670k
NCI NIH HHS K08 CA230170NIAID NIH HHS K01 AI118559NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI097045
6 · The paper itself

Abstract

Cancer patients are at higher risk of tuberculosis (TB) infection, especially in hospital settings with high TB/HIV burden. The study was implemented among adult patients admitted to the largest tertiary-level referral hospital in Botswana. We estimated the TB prevalence at admission and the rate of newly diagnosed TB after hospitalization in the medical and oncology wards, separately. Presumptive TB cases were identified at admission through symptom screening and underwent the diagnostic evaluation through GeneXpert. Patients with no evidence of TB were followed-up until TB diagnosis or the end of the study. In the medical and oncology wards, four of 867 admitted patients and two of 240 had laboratory-confirmed TB at admission (prevalence = 461.4 and 833.3 per 100,000, respectively.) The post-admission TB rate from the medical wards was 28.3 cases per 1,000 person-year during 424.5 follow-up years (post-admission TB rate among HIV-positive versus. -negative = 54.1 and 9.8 per 1,000 person-year, respectively [Rate Ratio = 5.5]). No post-admission TB case was detected from the oncology ward. High rates of undetected TB at admission at both medical and oncology wards, and high rate of newly diagnosed TB after admission at medical wards suggest that TB screening and diagnostic evaluation should target all patients admitted to a hospital in high-burden settings.

Indexed as

Mass ScreeningAdultFemaleHIV InfectionsHospitalizationHumansMiddle AgedNeoplasmsTertiary Care CentersTuberculosis

Identifiers

PMID31295315
PMCPMC6623960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.